🇺🇸 FDA
Patent

US 7855191

Agent having a destructive effect on malignant tumors and method for the production thereof

granted A61KA61K31/05A61K31/194

Quick answer

US patent 7855191 (Agent having a destructive effect on malignant tumors and method for the production thereof) held by C.Y.L. Pharmazeutika GmbH expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
C.Y.L. Pharmazeutika GmbH
Grant date
Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/05, A61K31/194, A61K31/198, A61K31/341